Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease

BACKGROUND/AIMS: The resistance rate of Helicobacter pylori is gradually increasing. We aimed to evaluate the efficacy of levofloxacin-based third-line H. pylori eradication in peptic ulcer disease. METHODS: Between 2002 and 2014, 110 patients in 14 medical centers received levofloxacin-based third-...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gut Liver
Hlavní autoři: Lim, Joo Hyun, Kim, Sang Gyun, Song, Ji Hyun, Hwang, Jae Jin, Lee, Dong Ho, Han, Jae Pil, Hong, Su Jin, Kim, Ji Hyun, Jeon, Seong Woo, Kim, Gwang Ha, Shim, Ki-Nam, Shin, Woon Geon, Kim, Tae Ho, Kim, Sun Moon, Chung, Il-Kwon, Kim, Hyun-Soo, Kim, Heung Up, Lee, Joongyub, Kim, Jae Gyu
Médium: Artigo
Jazyk:Inglês
Vydáno: Editorial Office of Gut and Liver 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347646/
https://ncbi.nlm.nih.gov/pubmed/27609487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl16099
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky